Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €133.32 EUR
Change Today -4.43 / -3.22%
Volume 4.4M
As of 3:55 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

bayer ag-reg (BAYN) Snapshot

Open
€137.73
Previous Close
€137.76
Day High
€138.60
Day Low
€133.26
52 Week High
04/13/15 - €146.45
52 Week Low
04/22/14 - €93.66
Market Cap
110.3B
Average Volume 10 Days
2.0M
EPS TTM
€4.56
Shares Outstanding
826.9M
EX-Date
05/28/15
P/E TM
29.2x
Dividend
€2.25
Dividend Yield
1.57%
Current Stock Chart for BAYER AG-REG (BAYN)

bayer ag-reg (BAYN) Related Bloomberg News

View More Bloomberg News

bayer ag-reg (BAYN) Details

Bayer Aktiengesellschaft develops, produces, and markets health care and agricultural products, and high-tech polymer materials worldwide. The company operates through HealthCare, CropScience, and MaterialScience segments. The HealthCare segment offers prescription pharmaceuticals, such as anticoagulants; medicines to treat hemophilia, multiple sclerosis, cancer, eye diseases, pulmonary hypertension, high blood pressure, and infectious diseases; and contraceptives, as well as provides consumer health products, including over-the-counter medications, dermatology products, nutritional supplements, veterinary medicines, and animal grooming products. This segment also provides medical care products, including blood glucose monitoring devices, such as single-strip and multi-strip systems; USB meters that feature integrated diabetes management software and direct plug-in to computers; and contrast agent injection systems for diagnostic and therapeutic medical procedures in X-ray, computed tomography, and magnetic resonance imaging. The CropScience segment offers products in the areas of seeds and plant traits, and crop protection; and products for use in gardens and non-agricultural pest control, as well as green industry. The MaterialScience segment provides high-tech polymer materials in the areas of polyurethanes, polycarbonates, coating and adhesive raw materials, and specialty chemicals; and selected inorganic basic chemicals. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

118,888 Employees
Last Reported Date: 02/25/15
Founded in 1863

bayer ag-reg (BAYN) Top Compensated Officers

Chairman of Management Board and Chief Execut...
Total Annual Compensation: €3.2M
Chief Financial Officer and Member of Managem...
Total Annual Compensation: €520.0K
Chief Strategy & Portfolio Officer and Member...
Total Annual Compensation: €2.0M
Labor Director and Member of Management Board
Total Annual Compensation: €1.6M
Member of Management Board, Chief Medical Off...
Total Annual Compensation: €1.4M
Compensation as of Fiscal Year 2014.

bayer ag-reg (BAYN) Key Developments

Bayer AG to Early Redeem EUR 1.3 Billion Bond Issued in 2005

Bayer AG plans to early redeem a EUR 1.3 billion bond. The first opportunity to repay the subordinated bond with a 5% coupon and a 100-year maturity issued in 2005 (ISIN XS0225369403) arises on July 29, 2015. The company has decided to utilize this repayment right. The company will arrange for publication of a formal investor notification in the newspaper Luxemburger Wort or through the clearing system in June 2015 in accordance with the bond conditions.

Bayer AG Proposes Dividend for the Year 2014

The Board of Management and the Supervisory Board of Bayer AG propose that the entire distributable profit of EUR 1,860,632,568.00 reported in the annual financial statements for the fiscal year 2014 be used to pay a dividend of EUR 2.25 per share carrying dividend rights, at the AGM to be held on May 27, 2015.

Bayer AG Proposes Amendment to the Articles of Incorporation

Bayer AG proposed amendment of the Object of the company (Section 2, Paragraph 1 of the Articles of Incorporation) to the AGM to be held on May 27, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYN:GR €133.32 EUR -4.43

BAYN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $297.05 USD +0.60
Bristol-Myers Squibb Co $65.35 USD +1.67
GlaxoSmithKline PLC 1,576 GBp -20.50
Novo Nordisk A/S kr376.90 DKK -5.50
Sanofi €95.65 EUR -1.37
View Industry Companies
 

Industry Analysis

BAYN

Industry Average

Valuation BAYN Industry Range
Price/Earnings 28.8x
Price/Sales 2.3x
Price/Book 4.9x
Price/Cash Flow 28.8x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-REG, please visit www.bayer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.